Q: What results should I expect
Clin Chem 46:10651071 Hustad S, Midttun , Schneede J, Vollset SE, Grotmol T (2007) The methylenetetrahydrofolate reductase 677C T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism
Wound Healing and Scar Improvement: Its proven ability to accelerate healing and stimulate organized collagen production makes it particularly valuable for addressing existing acne scars
Modifications to the peptide chain to reduce degradation by DPP-4, combined with acylation to promote non-covalent binding to albumin, resulted in long-acting formulations, enabling their use in clinical practice.3,5 Initially, GLP-1 receptor monoagonists were marketed with the aim of treating type 2 diabetes, harnessing their incretin effect and glucose-dependent mechanism, along with their capacity to reduce body weight and their beneficial effects on associated comorbidities.1,3,5 Subsequently, research shifted its focus to obesity, employing higher doses than those used for diabetes.3,5 This was followed by the development of unimolecular structures with multi-receptor activity, such as GIP/GLP-1 and GLP-1/glucagon (GCG) coagonists, as well as GIP/GLP-1/GCG triagonists
